Allarity Therapeutics (ALLR) Other Non-Current Assets (2020 - 2024)
Allarity Therapeutics' (ALLR) quarterly Other Non-Current Assets came in at $2.0 million in Q1 2024, up 3378.95% YoY from $57000.0 in Q2 2023, and up 3441.07% on a QoQ basis from $56000.0 in Q3 2023.
Allarity Therapeutics (ALLR) Other Non-Current Assets (2020 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 5 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q1 2024.
- Quarterly Other Non-Current Assets rose 3378.95% year-over-year to $2.0 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $2.0 million (up 3378.95% YoY) and the FY2022 annual result came in at $51000.0, down 3.77% from the prior year.
- Other Non-Current Assets advanced to $2.0 million in Q1 2024, from $56000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $37.5 million in Q2 2021 to a low of $47000.0 in Q3 2022.
- A 5-year average of $3.3 million and a median of $56500.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets slumped 99.86% — and 2024, when it soared 3378.95%.
- Tracing ALLR's Other Non-Current Assets over 5 years: stood at $68000.0 in 2020, then slipped by 22.06% to $53000.0 in 2021, then retreated by 3.77% to $51000.0 in 2022, then gained by 9.8% to $56000.0 in 2023, then soared by 3441.07% to $2.0 million in 2024.
- The last three Other Non-Current Assets figures came in at $2.0 million (Q1 2024), $56000.0 (Q3 2023), and $57000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.98 Mn |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Sep 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 57,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Jun 30, 2021 | 37.53 Mn |
| Dec 31, 2020 | 68,000.00 |